XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Net cash used in operating activities    
Net loss $ (43,114) $ (34,503)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 24,757 25,730
Non-cash interest 843 640
Amortization of deferred financing costs 43 56
Losses from investments in investees 2,456 2,131
Equity-based compensation – employees and non-employees 5,936 9,693
Loss (gain) on disposal of fixed assets (261) (2,997)
Change in fair value of equity securities and derivative instruments (3,101) (4,037)
Change in fair value of contingent consideration 1,759 2,371
Deferred income tax benefit (2,709) (9,236)
Changes in assets and liabilities, net of the effects of acquisitions:    
Accounts receivable, net 6,757 (17,771)
Inventory, net 204 (50)
Other current assets and prepaid expenses 5,445 4,692
Other assets (131) (235)
Accounts payable (10,206) 19,539
Foreign currency measurement (11) (69)
Contract liabilities (15,358) (13,849)
Accrued expenses and other liabilities (8,829) (16,024)
Net cash used in operating activities (35,520) (33,919)
Cash flows from investing activities:    
Investments in investees (1,000) 0
Proceeds from sale of equity securities 1,286 0
Proceeds from the sale of property, plant and equipment 541 3,095
Capital expenditures (5,973) (9,537)
Net cash used in investing activities (5,146) (6,442)
Cash flows from financing activities:    
Issuance of 2033 Senior Notes, net, including related parties 55,000 0
Proceeds from the exercise of Common Stock options and warrants 0 1,866
Borrowings on lines of credit 6,611 7,825
Repayments of lines of credit (12,420) (7,517)
Net cash provided by financing activities 49,191 2,174
Effect of exchange rate changes on cash and cash equivalents (81) 506
Net increase (decrease) in cash and cash equivalents 8,444 (37,681)
Cash and cash equivalents at beginning of period 91,499 168,733
Cash and cash equivalents at end of period 99,943 131,052
SUPPLEMENTAL INFORMATION:    
Interest paid 641 550
Income taxes paid, net of refunds 2,292 848
Shares issued upon the conversion of:    
Common Stock options and warrants, surrendered in net exercise $ 0 $ 696